메뉴 건너뛰기




Volumn 35, Issue 5, 2012, Pages 823-829

Heterogeneity of follow-up procedures in French and Belgian patients with treated hereditary tyrosinemia type 1: Results of a questionnaire and proposed guidelines

Author keywords

[No Author keywords available]

Indexed keywords

NITISINONE;

EID: 84866743177     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9429-y     Document Type: Article
Times cited : (17)

References (14)
  • 1
    • 0036329063 scopus 로고    scopus 로고
    • Corneal opacities associated with NTBC treatment
    • Ahmad S, Teckman JH, Lueder GT (2002) Corneal opacities associated with NTBC treatment. Am J Ophthalmol 134:266-268
    • (2002) Am J Ophthalmol , vol.134 , pp. 266-268
    • Ahmad, S.1    Teckman, J.H.2    Lueder, G.T.3
  • 2
    • 78049452264 scopus 로고    scopus 로고
    • Recommendations and management of type I hereditary or hepatorenal tyrosinemia
    • e1-e4
    • Couce ML, Aldamiz-Echevarria L, Baldellou A et al. (2010) Recommendations and management of type I hereditary or hepatorenal tyrosinemia. An Pediatr (Barc) 73(5)279.e1-e4
    • (2010) An Pediatr (Barc) , vol.73 , Issue.5 , pp. 279
    • Couce, M.L.1    Aldamiz-Echevarria, L.2    Baldellou, A.3    Et Al.4
  • 3
    • 80052553877 scopus 로고    scopus 로고
    • Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1
    • De Laet C, Munoz VT, Jaeken J et al. (2011) Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1. Dev Med Child Neurol 53:962-964
    • (2011) Dev Med Child Neurol , vol.53 , pp. 962-964
    • De Laet, C.1    Munoz, V.T.2    Jaeken, J.3    Et Al.4
  • 4
    • 0029070081 scopus 로고
    • Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4- trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesul- fonylbenzoyl)-cyclohexane-1,3-dione
    • Ellis MK, Whitfield AC, Gowans LA et al. (1995) Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)- cyclohexane-1,3-dione and 2-(2-chloro-4-methanesul-fonylbenzoyl)-cyclohexane-1, 3-dione. Toxicol Appl Pharmacol 133:12-19
    • (1995) Toxicol Appl Pharmacol , vol.133 , pp. 12-19
    • Ellis, M.K.1    Whitfield, A.C.2    Gowans, L.A.3    Et Al.4
  • 6
    • 0035196687 scopus 로고    scopus 로고
    • The pathophysiology and treatment of hereditary tyrosinemia type 1
    • Grompe M (2001) The pathophysiology and treatment of hereditary tyrosinemia type 1. Semin Liver Dis 21:563-571
    • (2001) Semin Liver Dis , vol.21 , pp. 563-571
    • Grompe, M.1
  • 7
    • 33750619591 scopus 로고    scopus 로고
    • Tyrosinemia type I treated by NTBC: How does AFP predict liver cancer?
    • Koelink CJ, van Hasselt P, van der Ploeg A et al. (2006) Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer? Mol Genet Metab 89:310-315
    • (2006) Mol Genet Metab , vol.89 , pp. 310-315
    • Koelink, C.J.1    Van Hasselt, P.2    Van Der Ploeg, A.3    Et Al.4
  • 8
    • 0026675589 scopus 로고
    • Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase
    • Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340:813-817
    • (1992) Lancet , vol.340 , pp. 813-817
    • Lindstedt, S.1    Holme, E.2    Lock, E.A.3    Hjalmarson, O.4    Strandvik, B.5
  • 10
    • 40849102507 scopus 로고    scopus 로고
    • NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients
    • Masurel-Paulet A, Poggi-Bach J, Rolland MO et al. (2008) NTBC treatment in tyrosinaemia type I: long-term outcome in French patients. J Inherit Metab Dis 31:81-87
    • (2008) J Inherit Metab Dis , vol.31 , pp. 81-87
    • Masurel-Paulet, A.1    Poggi-Bach, J.2    Rolland, M.O.3    Et Al.4
  • 11
    • 33646766481 scopus 로고    scopus 로고
    • Nitisinone in the treatment of hereditary tyrosi-naemia type 1
    • McKiernan PJ (2006) Nitisinone in the treatment of hereditary tyrosi-naemia type 1. Drugs 66:743-750
    • (2006) Drugs , vol.66 , pp. 743-750
    • McKiernan, P.J.1
  • 12
    • 0032703352 scopus 로고    scopus 로고
    • Indications and outcome of liver transplantation in tyrosinaemia type 1
    • Mohan N, McKiernan P, Preece MA et al. (1999) Indications and outcome of liver transplantation in tyrosinaemia type 1. Eur J Pediatr 158(Suppl 2):S49-S54
    • (1999) Eur J Pediatr , vol.158 , Issue.SUPPL. 2
    • Mohan, N.1    McKiernan, P.2    Preece, M.A.3    Et Al.4
  • 14
    • 0028089988 scopus 로고
    • Hereditary tyrosinemia type I: A new clinical classification with difference in prognosis on dietary treatment
    • van Spronsen FJ, Thomasse Y, Smit GP et al. (1994) Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment. Hepatology 20:1187-1191
    • (1994) Hepatology , vol.20 , pp. 1187-1191
    • Van Spronsen, F.J.1    Thomasse, Y.2    Smit, G.P.3    Et Al.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.